FDA approves twice-yearly lenacapavir as PrEP for HIV in adolescents, adults
Lenacapavir is the first twice-yearly option available in the US for those who need or want PrEP, according to Gilead Sciences.
Food Insecurity and the Dangers of Infant Formula Dilution
A headache with a red flag in a 10-year-old girl
The patient described the headache as “pressure-like,” episodes that occurred for 1 to 2 hours with high severity.
Demystifying Infant Formula
AAP updates guidance on contraception for adolescents
The American Academy of Pediatrics urges clinicians to offer confidential, adolescent-centered contraceptive care using evidence-based, equity-informed approaches.
FDA accepts NDA for epinephrine sublingual film to treat type 1 allergic reactions
The federal agency has assigned a target action date of January 31, 2026, for a decision.
